A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

This study is ongoing, but not recruiting participants.

Study NCT01306617 Information provided by Abbott

First Received: February 28, 2011 Last Updated: March 19, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	October 2012
Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)